Dr. Christopher G. Peterson, MD

Dr. Peterson practices at Aspirus Wausau Hospital in Wausau, Wisconsin, part of Aspirus.

Dr. Peterson's NPI, 1700897535, was assigned on August 10, 2006. Dr. Peterson graduated from Medical College of Wisconsin in 1998. Dr. Peterson holds Wisconsin license 41432.

Dr. Peterson's primary practice is Aspirus Wausau Hospital, at 333 Pine Ridge Blvd, Wausau, WI 54401 in Marathon County. The practice phone is (715) 847-2000.

Dr. Peterson's primary practice is Aspirus Wausau Hospital in Wausau, Wisconsin, part of Aspirus. Dr. Peterson is also affiliated with Aspirus Rhinelander Hospital. The medical group on file is Aspirus Langlade Hospital. Dmand AI also links Dr. Peterson to 3 more hospitals, 5 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Peterson practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Peterson's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Peterson is licensed in Wisconsin.

CMS data shows 1,346 Medicare services from Dr. Peterson across 9 procedure codes in 2024, for 356 Medicare patients. Medicare paid $56,111 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 356 Medicare patients who saw Dr. Peterson in 2024. The largest group is 65 to 74, with 198 patients. 66% of them have high cholesterol, and 63% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Peterson's median patient age at 71, with 56% women.

In 2024, Dr. Peterson wrote 2,449 Medicare Part D claims for 382 patients. 72% of them were for generic drugs. CMS names the drug for 2,069 of them, across 54 drugs with 11 or more claims each, at $9,447,858 in total drug cost. In 2023, CMS named 2,165 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Peterson for performance year 2024, reported as part of a group. Dr. Peterson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Peterson as offering telehealth.

Dmand AI links 12 papers to Dr. Peterson, published from 2011 to 2025. 2011 was the busiest year, with 2. The most frequent topics are Ecosystem, Human Activities and Organic Chemicals. Dr. Peterson's most frequent co-authors are Stephen J. Schuster, MD, Jules H. Blank, MD and Julie Elizabeth Chang, MD.

Dmand AI links Dr. Peterson to 10 clinical trials, 7 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 6.

CMS Open Payments shows 55 general payments to Dr. Peterson from 16 drug and device companies from 2016 to 2025. Education make up the largest share, 81% of the total. Exelixis Inc. paid the most, $1,806.

Dr. Peterson graduated from Medical College of Wisconsin in 1998.